Atai Life Sciences Revenue 2020-2025 | ATAI

Atai Life Sciences revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Atai Life Sciences Annual Revenue
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $20
2020 $0
2019 $0
Atai Life Sciences Quarterly Revenue
(Millions of US $)
2025-03-31 $2
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31
2021-12-31 $0
2021-09-30 $0
2021-06-30
2021-03-31 $20
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.411B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.898B 19.61
Encompass Health (EHC) United States $12.270B 26.01
DaVita (DVA) United States $11.006B 15.48
Chemed (CHE) United States $8.507B 26.74
Elanco Animal Health (ELAN) United States $6.496B 13.91
Option Care Health (OPCH) United States $5.415B 24.14
RadNet (RDNT) United States $4.514B 286.48
Amedisys (AMED) United States $3.109B 20.91
LifeStance Health (LFST) United States $2.267B 0.00
Addus HomeCare (ADUS) United States $2.070B 22.73
Astrana Health (ASTH) United States $1.518B 37.61
U.S Physical Therapy (USPH) United States $1.206B 31.14
Aveanna Healthcare Holdings (AVAH) United States $1.122B 63.89
Pennant (PNTG) United States $1.014B 37.25
MEDIROM Healthcare Technologies (MRM) Japan $0.037B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00